Torrent Pharmaceuticals Q1 FY26: Profit up 20%, margin 32.5%

Key takeaway from the June quarter

Torrent Pharmaceuticals Limited reported a strong set of numbers for the quarter ended June 2025 (Q1 FY26), with revenue rising 11% year-on-year to INR 3,178 crore and consolidated net profit increasing nearly 20% to INR 548 crore. The performance was supported by growth across key markets including India, the US, Brazil and Germany. Branded markets contributed 72% of quarterly revenue, as per the company’s earnings commentary. The company also flagged foreign exchange losses and one-off acquisition expenses that influenced reported profitability. Despite these items, operating profitability remained firm, with management highlighting margin stability.

Headline financials: revenue, profit and operating metrics

Total revenue for the quarter came in at INR 3,178 crore, compared with INR 2,859 crore in the year-ago quarter. Net income rose to INR 548 crore from INR 457 crore. Operating income was reported at INR 831 crore versus INR 707 crore a year earlier, reflecting improvement in operating performance.

Torrent reported operating EBITDA of INR 1,032 crore, up 14% year-on-year, with an operating EBITDA margin of 32.5% for the quarter. Gross margin stood at 76%. The company also disclosed an adjusted operating margin of 32.9% after excluding one-off acquisition-related expenses, which were referenced as INR 13 crore in the earnings summary and INR 15 crore in the earnings call commentary.

Market-wise performance: India, US, Brazil and Germany

India remained the largest contributor, with India revenues at INR 1,811 crore, up 11% year-on-year. Management said India growth outpaced the broader Indian pharmaceutical market, citing AIOCD Pharmatrac secondary market data that placed IPM growth at 8% for the quarter.

International markets also showed healthy momentum. US business revenues were reported at INR 308 crore, up 19% year-on-year. Germany revenues were INR 308 crore, rising 9% year-on-year. Brazil revenues were INR 218 crore, up 11% year-on-year, while the company also noted Brazil growth of 16% in constant currency terms.

Costs, expenses and profitability levers

The quarterly data table provided with the results shows total operating expense at INR 2,347 crore for the June 2025 quarter, compared with INR 2,152 crore in June 2024. Selling, general and administrative expenses were INR 605 crore, up from INR 550 crore in the year-ago quarter. Other operating expenses totalled INR 767 crore, compared with INR 711 crore a year earlier.

Depreciation and amortisation was INR 201 crore for the quarter, marginally higher than INR 197 crore in the year-ago period. The company’s diluted normalised EPS was reported at INR 16.19 for the quarter, up from INR 13.51 in the comparable quarter.

Forex loss and one-off acquisition expenses

Torrent said it booked a foreign exchange loss of INR 48 crore in other income, mainly due to euro and US dollar translation losses. It also highlighted acquisition-related one-off expenses during the quarter, and provided an adjusted operating margin calculation that excludes these costs. The adjusted operating margin was stated at 32.9%, and management indicated it expects at least this level of margin for the rest of FY26.

How the results compared with expectations

A Reuters report cited that Torrent’s total revenue rose 11% to INR 3,178 crore, exceeding analysts’ estimate of INR 3,157 crore, based on LSEG data. Reuters also attributed profit growth to higher demand for medicines aimed at managing chronic illnesses.

Stock market reaction and investor focus

In the session referenced in the provided text, Torrent Pharmaceuticals stock closed at INR 3,630, up INR 26.20 or 0.73%, compared with the previous close of INR 3,603.80. For investors, the focus areas from the quarter include the durability of branded-market growth, the trajectory of operating margins after adjusting for one-offs, and the impact of currency movements on reported profitability.

Summary table: Q1 FY26 versus prior periods

Geography snapshot: reported revenues for the quarter

What to track next

Torrent’s commentary points to continued emphasis on branded markets, where it said 72% of Q1 revenue was generated. Management’s margin stance, including the 32.9% adjusted operating margin benchmark, will likely remain a key reference for upcoming quarters. Investors will also watch for the persistence of forex-related volatility after the INR 48 crore loss recorded in the quarter, and for any further disclosures around acquisition-related costs.